Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6431 matches for

Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20 million in Series A financing.

Career Development

Other Professional Development Opportunities

Research Best Practice

Explore the links below to learn more about best practice for researchers at Oxford.

Departments, Networks & Clinical Trial Units

Development of a semi-automated CT-brain analysis tool for application to real world clinical cohorts

Development of bioactive ultrasound-responsive coatings for the prevention and treatment of orthopaedic implant-related infections

Developing translatable TetraVecta-enabled allogeneic regulatory T cell therapy

High-throughput characterisation of the functional antibody epitope landscape of surface protein targets to guide vaccine and biologic design

Understanding the molecular reach of therapeutic CD3-targeting bi-specific antibodies to optimise efficacy

An integrative mathematical approach to understand how intraplaque angiogenesis and vascular structure impact atherosclerosis and their potential as novel therapeutic targets

Target enrichment of transposable elements for direct RNA sequencing

Technological Advancements In Radiotherapy Leading To Dose Delivery via FLASH

Single Particle Liquid Biopsy Analysis for Acute Myocardial Infarction

Neutrophil subset behaviour in vascular and tissue microenvironment: organ-on-a-chip

Ageing Beyond Earth - new drug targets

Unravelling the effects of mitochondrial replacement therapy on mtDNA transmission

Utilising administrative data to inform FIT-guided suspected colorectal cancer referrals of symptomatic patients

Cross-tissue and cross-disease immunometabolic landscape characterisation at single-cell resolution

Imaging-based analysis of signalling pathways triggered by immune checkpoint receptors

A Novel K+ Channel Target (KCNK13/THIK1) for Neurodegenerative Disorders: Understanding its mechanism of inhibition by small molecule drugs and biological therapeutics

Load More

Similar stories